Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-06-16

FDA Approved: LOTREL — Supplemental Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

FDA approved a supplemental application for Lotrel (amlodipine besylate and benazepril hydrochloride) submitted by Novartis Pharmaceuticals Corporation. The app…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LOTREL (amlodipine besylate and benazepril hydrochloride)

Snippet

SUPPL AP for LOTREL (AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE)